Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Erb

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Pharmaceutical Research|February 1, 1993
Introduction to backpropagation neural network computationR J Erb
Clinical Pharmacokinetics|August 1, 1995
The backpropagation neural network--a Bayesian classifier. Introduction and applicability to pharmacokineticsR J Erb
Journal of Pharmaceutical Sciences|August 1, 1982
Serum prolactin level increase in normal subjects following administration of perphenazine oral dosage forms: possible application to bioavailability testingR J Erb, W P Stoltman
Journal of Pharmaceutical Sciences|March 1, 1977
Predictive conversion of in vitro drug dissolution data into in vivo drug response versus time profiles exemplified for plasma levels of warfarinV F Smolen, R J Erb
Clinical Pharmacology and Therapeutics|March 1, 1988
Tolerance to alprazolam after intravenous bolus and continuous infusion: psychomotor and EEG effectsP D Kroboth, R B Smith, R J Erb
Journal of Pharmaceutical Sciences|August 1, 1970
In vivo electrometric study of carcinogenic hydrocarbon interaction with mouse epidermisV F Smolen, D E Snyder, R J Erb
Pharmaceutical Research|July 1, 1991
Pharmacodynamics and biophasic drug levels of methionine enkephalinR J Erb, L M Her, A Abdallah, et al.
Clinical Pharmacology and Therapeutics|January 1, 1981
Digital plethysmography for assessing erythrityl tetranitrate bioavailabilityR E Hannemann, R J Erb, W P Stoltman, et al.
Clinical Pharmacology and Therapeutics|November 1, 1994
The pharmacokinetic-pharmacodynamic (Digit Symbol Substitution Test) relationship of flumazenil in a midazolam steady-state model in healthy volunteersJ Zhi, J W Massarella, A T Melia, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Pharmaceutical Research|February 1, 1993
Introduction to backpropagation neural network computationR J Erb
Clinical Pharmacokinetics|August 1, 1995
The backpropagation neural network--a Bayesian classifier. Introduction and applicability to pharmacokineticsR J Erb
Journal of Pharmaceutical Sciences|August 1, 1982
Serum prolactin level increase in normal subjects following administration of perphenazine oral dosage forms: possible application to bioavailability testingR J Erb, W P Stoltman
Journal of Pharmaceutical Sciences|March 1, 1977
Predictive conversion of in vitro drug dissolution data into in vivo drug response versus time profiles exemplified for plasma levels of warfarinV F Smolen, R J Erb
Clinical Pharmacology and Therapeutics|March 1, 1988
Tolerance to alprazolam after intravenous bolus and continuous infusion: psychomotor and EEG effectsP D Kroboth, R B Smith, R J Erb
Journal of Pharmaceutical Sciences|August 1, 1970
In vivo electrometric study of carcinogenic hydrocarbon interaction with mouse epidermisV F Smolen, D E Snyder, R J Erb
Pharmaceutical Research|July 1, 1991
Pharmacodynamics and biophasic drug levels of methionine enkephalinR J Erb, L M Her, A Abdallah, et al.
Clinical Pharmacology and Therapeutics|January 1, 1981
Digital plethysmography for assessing erythrityl tetranitrate bioavailabilityR E Hannemann, R J Erb, W P Stoltman, et al.
Clinical Pharmacology and Therapeutics|November 1, 1994
The pharmacokinetic-pharmacodynamic (Digit Symbol Substitution Test) relationship of flumazenil in a midazolam steady-state model in healthy volunteersJ Zhi, J W Massarella, A T Melia, et al.
Pageof 1